Total Funding
34
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Ablatus Therapeutics is a a UK-based medical device.
- Anne Blackwood: Non Executive DirectorPast Role: London South Bank University, Research Fellow
- Heather Carre-Skinner: Head Of Regulatory AffairsPast Role: Congenica, Quality Assurance and Regulatory Affairs Manager
About the Company
Ablatus Therapeutics Ltd, a medical device company, has been founded to develop and commercialise a novel tissue ablation technology to treat the most challenging and often inoperable, solid cancer tumours.
